Skip to content

Establishment and popularization of postpartum integrated management system in gestational diabetes mellitus

Establishment and popularization of postpartum integrated management system in gestational diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084542
Enrollment
Unknown
Registered
2024-05-20
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal postnatal glucose metabolism in pregnant women with gestational diabetes mellitus (including type 2 diabetes, impaired fasting glucose and impaired glucose tolerance)

Interventions

Regular Care Group (RCT):Accept traditional standard postpartum management measures.
Enhanced Lifestyle Intervention Group (RCT):Implementing a joint online and offline management plan of "hospital community family" using information systems
Postpartum glucose metabolism abnormalities group (prospective cohort):None
Postpartum normal glucose metabolism group (prospective cohort):None

Sponsors

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: 1: Prospective cohort: Age range from 18 to 44 years old; GDM pregnant women who undergo regular prenatal examinations and delivery in the hospital; Singleton pregnancy. 2: RCT: Age range from 18 to 44 years old; GDM pregnant women who undergo regular prenatal examinations and delivery in the hospital; Singleton pregnancy.

Exclusion criteria

Exclusion criteria: 1: Prospective cohort: Multiple pregnancies; History of hepatitis, nephritis, digestive tract diseases (chronic gastritis, enteritis, gastric ulcer, duodenal ulcer, etc.) and infectious diseases (hepatitis, tuberculosis, etc.); Metabolic diseases (diabetes, hyperlipidemia, thyroid diseases, etc.) before pregnancy; Mental diseases; Structural abnormalities of newborns; Fetal/newborn chromosome or genome abnormalities; Incomplete clinical data; Individuals who refuse to participate in the study or are unable to follow the study plan for follow-up visits will not be included in this study. 2: RCT: Multiple pregnancies; History of hepatitis, nephritis, digestive tract diseases (chronic gastritis, enteritis, gastric ulcer, duodenal ulcer, etc.) and infectious diseases (tuberculosis, etc.); Metabolic diseases (diabetes, thyroid diseases, etc.) before pregnancy; Mental illnesses; Incomplete clinical data; Individuals who are unable or unwilling to participate in intervention and follow-up, as well as those who are not suitable for exercise, are not included in this study.

Design outcomes

Primary

MeasureTime frame
75g oral glucose tolerance test (OGTT);low-dentisty lipoprotein cholesteral;

Secondary

MeasureTime frame
fasting insulin;cholesteral;triglyceride;high-dentisty lipoprotein cholesteral;

Countries

China

Contacts

Public ContactLi Guanghui

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

liguanghui@ccmu.edu.cn+86 131 2472 8821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026